00:00futures under pressure ahead of Thursday's open here today. S&P futures down 0.2 percent. Dow
00:12futures down 0.38 percent. And the Nasdaq futures down 0.29 percent. It's about sideways. I guess
00:20it was a little bit lower in the after hour session, but really has made no significant move
00:25yet as of today or as of this morning. Let's go ahead and take a look at some cues from last
00:31session. Materials, utilities and industrial stocks recorded the biggest losses on Wednesday,
00:37though health care and communication services bucked the trend, closed the session higher.
00:43However, investors remain highly vigilant regarding headline risk. The U.S. Supreme Court could
00:49make a ruling on the tariffs imposed on other countries by Trump as early as Friday. So that
00:56would be tomorrow. The Supreme Court had said it will hold an opinion day on Friday with justices
01:01back from break. Additionally, investors also await the December jobs report slated to be released on
01:07Friday as well. Meanwhile, the 10-year Treasury bond yielded 4.15 percent and the two-year bond yielded
01:143.47 percent. Also worth noting, since we've been talking about rate cuts quite a bit going into
01:202026, the CME Group's Fed Watch Tool projections are showing markets pricing in an 88.4 percent
01:27likelihood of the Federal Reserve leaving the current rates unchanged in January. And this should
01:33be no surprise. I'm pretty sure a majority of the group was on this side for this next one. We're not
01:39really expecting a cut, and I would imagine the market feels the same on that. First stock in
01:45focus is going to be AZZ. I guess that's AS. It was 2.8 percent higher in the pre-market on Thursday
01:53after the company reported upbeat earnings for the third quarter. The next stock on our list here is
01:59one we've traded before off of some PRs in the morning and off the relative volume scanner. It's going
02:04to be Immunaring. That's ticker IMRX. Shares tumbled 22.93 percent after it announced updated
02:11overall survival and safety data from its ongoing phase 2A trial of one of its drugs in combination
02:18with modified another drug in first-line pancreatic cancer patients with over 13 months of median follow-up
02:26time. So looks like not good data on that. Stock is slumping as a result of that.
02:32Northrop Grumman is the next stock on our list. That's ticker NOC. That jumped 6.84 percent as
02:39shares of defense companies traded higher following President Trump's social media report where he
02:44proposed increasing the 2027 military budget from $1 trillion to $1.5 trillion. Phantom Pharmaceuticals
02:52is the next stock on our list here. Ticker is PHAT, FAT. It dropped 14.22 percent after announcing
03:00the pricing of $130 million public offering of common stock and pre-funded warrants.
03:07The last stock on our list is Constellation Brands. This was a stock on our list yesterday.
03:12They're on the list again today because shares were 2.32 percent higher after posting better than
03:17expected earnings for the third quarter. It's also worth noting that STZ has maintained a strong
03:23short and medium-term price trend has not yet converted that long trend over.
Comments